Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 1/20 | 0.31 |
| ▸ | HTR2C | P28335 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | AR | P10275 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9949885 | 0.86 | AR (0.31) | AR | |
| SCHEMBL10082847 | 0.77 | — | — | |
| SCHEMBL9949591 | 0.76 | TDP1 (0.39) | KDM4E | |
| SCHEMBL15255467 | 0.76 | — | — | |
| SCHEMBL12724676 | 0.72 | AR (0.34) | AR | |
| SCHEMBL10053357 | 0.72 | SMN1; SMN2 (0.33) | MEN1LMNAKMT2A | |
| SCHEMBL12724677 | 0.71 | P2RX7 (0.40) | HTR2AHTR2CAR | |
| SCHEMBL19918780 | 0.71 | P2RX7 (0.38) | HTR2AHTR2CAR | |
| SCHEMBL1231290 | 0.70 | HPD (0.43) | — | |
| SCHEMBL596967 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2658841-B1 | PROCESS FOR PREPARING 3-ALKYLSULFINYLBENZOYL DERIVATIVES | BAYER IP GMBH (DE) | 2017-09-20 | — | — | EP | disclosed |
| EP-2658841-A1 | PROCESS FOR PREPARING 3-ALKYLSULFINYLBENZOYL DERIVATIVES | Bayer Intellectual Property GmbH (DE) | 2013-11-06 | — | — | EP | disclosed |
| US-8455657-B2 | Process for the preparation of 3-alkylsulfinylbenzoyl derivatives | BAYER CROPSCIENCE AG (DE) | 2013-06-04 | — | — | US | disclosed |
| WO-2012089644-A1 | PROCESS FOR PREPARING 3-ALKYLSULFINYLBENZOYL DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2012-07-05 | — | — | WO | disclosed |
| US-20120165540-A1 | PROCESS FOR THE PREPARATION OF 3-ALKYLSULFINYLBENZOYL DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2012-06-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120165540-A1 | PROCESS FOR THE PREPARATION OF 3-ALKYLSULFINYLBENZOYL DERIVATIVES | CBR3, CBR1, CYP1B1 | HTR2A 2558/4885HTR2C 2639/4885KDM4E 1445/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.